The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
similarly with the PSA by itself virtually meaningless but PSA density PSA velocity now adds much more uh specificity uh furthermore you start to add things like a 4K and if the risk is high enough you get um you know multiparametric MRI
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
in 10 years I have not had one patient get a prostate biopsy that wasn't warranted and I'm not a superstar it's not like I've I've got something no it's just that we're we're doing this we're not just using PSA right sometimes we've had patients who only get picked up on PSA velocity their PSA is not high enough to trigger the 4K no one would go and do anything based on their you know